Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Trading Statement

22 Jul 2013 07:00

RNS Number : 7806J
HaiKe Chemical Group Ltd.
22 July 2013
Β 

ο»Ώ

Β 

HaiKe Chemical Group Ltd

Β 

Trading Update

Β 

HaiKe Chemical Group Limited ("HaiKe" or the "Company" or the "Group"), the AIM quoted (AIM: HAIK) petrochemical, speciality chemical and biochemical business based in China, today provides an update on trading ahead of its interim results for the six months period ended 30 June 2013.

Β 

The final results announced on 20 May 2013 noted that the Group performance has been impacted by lower utilisation rates and unfavourable feedstock prices in the refinery division and sluggish demand in the chemical business. In the first six months of 2013, these factors continued to have significant negative effects on the business, resulting in losses widening to approximately CNY327 million (H1 2012: CNY212.8 million) and further increases in bank borrowings. The banks continue to be supportive of the Group.

Β 

In the refinery business, the new pricing mechanism which has relaxed pricing controls over refined products in the domestic market has been implemented and we observed that most of the price adjustments were made on time. However, since the aim of the new pricing mechanism is to improve the transparency and predictability of the retail price of refined products and reduce the misalignment between the feedstock price and the retail price, the mechanism itself does not guarantee a positive average industry margin.

Β 

The performance of chemical products in H1 was mixed. Most products recorded an increase in sales volume as a result of more aggressive marketing efforts, but falling prices as a result of sluggish domestic demand have led to falling margins. Biochemicals delivered a comparable sales turnover but a decrease in profit as a result of a reduction in margins.

Β 

The difficult operating environment has impacted gross margins at Group level which fell further to approximately 0.3% in H1 2013 from 1.2% in H1 2012. Selling, general and administration expenses increased significantly due increased marketing spend. Balance sheet and cash flow positions have deteriorated as a result of increased losses. During the first half of this year, the Company's short-term debt increased by approximately CNY575 million to CNY6.6 billion as a result of an increase in bank borrowings. Negative operating cashflow before working capital changes was CNY102.1 million (2012: CNY28.3 million) and working capital has tightened.

Β 

The Board of HaiKe is disappointed by the performance of the business. The Company is considering its options given the difficult operating environment and will update shareholders when appropriate.

Β 

For further information please contact:

Β 

HaiKe Chemical Group

George Zeng, Chief Financial Officer

george@haikechemical.com

+86 138 2520 2570

Westhouse Securities

Martin Davison / Jonathan Haines

Β 

+44 (0) 20 7601 6100

Cardew Group

Shan Shan Willenbrock

Tom Horsman

haike@cardewgroup.comΒ 

+44 (0) 20 7930 0777

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTKMGZNFMLGFZM
Date   Source Headline
19th Mar 20182:38 pmRNSExit Facility and Cancellation
12th Mar 20188:07 amRNSResult of EGM
16th Feb 20187:00 amRNSProposed Cancellation, EGM and Exit Facility
16th Jan 201810:00 amRNSTrading Update
21st Sep 20173:16 pmRNSHolding(s) in Company
1st Sep 20177:00 amRNSHalf-year Report
26th Jun 20177:00 amRNSResult of AGM and Company Update
2nd Jun 20175:11 pmRNSAnnual Financial Report
1st Jun 20177:12 amRNSFinal Results
26th May 201710:43 amRNSBoard Appointment
23rd Jan 20178:00 amRNSTrading Statement
27th Sep 20167:36 amRNSHalf-year Report
6th Sep 20167:09 amRNSTrading Update - Correction
20th Jul 20167:00 amRNSDirectorate Change
27th Jun 201611:38 amRNSResult of AGM
3rd Jun 201611:59 amRNSAnnual Financial Report
31st May 20167:00 amRNSFinal Results
11th May 20169:01 amRNSNotice of Results and Update
8th Jan 201610:38 amRNSTrading Statement
6th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20157:00 amRNSTrading Statement
8th Jun 20157:00 amRNSResult of AGM
14th May 201512:38 pmRNSAnnual Financial Report and Notice of AGM
1st May 20157:00 amRNSFinal Results
23rd Jan 20157:00 amRNSTrading Statement
30th Sep 20148:02 amRNSHalf Yearly Report
21st Jul 20147:00 amRNSResult of AGM
30th Jun 201410:15 amRNSPosting of Annual Report and Accounts
25th Jun 20147:00 amRNSFinal Results
15th May 20148:23 amRNSResult of General Meeting
29th Apr 201411:59 amRNSProposed Restructuring of the Group
13th Dec 20138:55 amRNSTrading Statement
20th Sep 20137:00 amRNSHalf Yearly Report
22nd Jul 20137:00 amRNSTrading Statement
8th Jul 201310:02 amRNSResult of AGM
12th Jun 20139:04 amRNSNotice of AGM and Posting of Annual Report
20th May 20137:00 amRNSFinal Results
29th Apr 20139:30 amRNSDirectorate Change
15th Feb 201310:56 amRNSDirectorate Change
25th Jan 20137:00 amRNSTrading Update
21st Jan 201310:18 amRNSDirectorate Change
1st Oct 20127:00 amRNSDirectorate Change
7th Sep 201210:51 amRNSHalf Yearly Report
31st Jul 20128:36 amRNSTrading Statement
17th Jul 20127:13 amRNSDividend Payment
17th Jul 20127:10 amRNSBuyout of key refinery subsidiary
19th Jun 20127:00 amRNSResult of AGM and Trading Update
29th May 20122:18 pmRNSDirector/PDMR Shareholding
28th May 201212:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.